Prolactin potentiates transforming growth factor α induction of mammary meoplasia in transgenic mice

American Journal of Pathology

Volumn 168, Issue 4, 2006, Pages 1365-1374

  Arendt, Lisa M ^a,b   Rose Hellekant, Teresa A ^a,c   Sandgren, Eric P ^a   Schuler, Linda A ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; LIPOCALIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CYST; BREAST DEVELOPMENT; BREAST DUCT; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRECANCER AND CANCER-IN-SITU; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION;

EID: 33645459542     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050861     Document Type: Article

References (60)

1. Clevenger CV, Furth PA, Hankinson SE, Schuler LA: Role of prolactin in mammary carcinoma. Endocr Rev 2003, 24:1-27
2. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV: Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 1997, 138:5555-5560
3. Mertani HC, Garcia-Caballero T, Lambert A, Gérard F, Palayer C, Boulin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G: Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 1998, 79:202-211
4. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F, Kelly PA: Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 1998, 83:667-674
5. Vonderhaar BK: Prolactin in human breast cancer development. Endocrine Oncology. Edited by SP Ethier. Totawa, NJ, Humana Press, 2000, pp 101-120
6. Goffin V, Bernichtein S, Touraine P, Kelly PA: Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 2005, 26:400-422
7. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OGP, Törnell J: Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 1997, 100:2744-2751
8. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA: Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice. Oncogene 2003, 22:4664-4674
9. Yarden Y: The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001, 37:S3-S8
10. Troyer KL, Lee DC: Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia 2001, 6:7-21
11. Holbro T, Civenni G, Hynes NE: The ErbB receptors and their role in cancer progression. Exp Cell Res 2003, 284:99-110
12. Stern DF: ErbBs in mammary development. Exp Cell Res 2003, 284:89-98
13. Hurst HC: Regulation of EGR and ErbB2 expression by estrogen receptor in breast cancer. Endocrine Oncology. Edited by SP Ethier. Totawa, NJ, Humana Press, 2000, pp 69-77
14. Ethier SP: Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst 1995, 87:964-973
15. Salomon DS, Bianco C, De Santis M, Martinez-Lacaci I, Wechselberger C, Ebert AD: Epidermal growth factor-related peptides in endocrine neoplasias. Endocrine Oncology. Edited by SP Ethier. Totawa, NJ, Humana Press, 2000, pp 137-192
16. De Bortoli M, Dati C: Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland. J Mammary Gland Biol Neoplasia 1997, 2:175-185
17. Nicholson RI, Hutcheson IR, Knowlden JM, Jones HE, Harper ME, Jordan N, Hiscox SE, Barrow D, Gee JM: Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination. Clin Cancer Res 2004, 10:3465-3545
18. Humphreys RC, Hennighausen L: Transforming growth factor alpha and mouse models of human breast cancer. Oncogene 2000, 19:1085-1091
19. Matsui Y, Halter SA, Holt JT, Hogan BL, Coffey RJ: Development of mammary hyperplasia and neoplasia in MMTV-TGF-alpha transgenic mice. Cell 1990, 61:1147-1155
20. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC: Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990, 61:1121-1135
21. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT: TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990, 61:1137-1146
22. Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC: Inhibition of mammary gland involution is associated with transforming growth factor a but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 1995, 55:3915-3927
23. Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G: Transforming growth factor-α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol 1995, 147:1081-1096
24. Johnson JL, Fenton SE, Sheffield LG: Prolactin inhibits epidermal growth factor-induced ras-MAPK signaling in mammary epithelial cells. J Biol Chem 1996, 271:21574-21578
25. Quijano VJ Jr, Sheffield LG: Prolactin decreases epidermal growth factor receptor kinase activity via a phosphorylation-dependent mechanism. J Biol Chem 1998, 273:1200-1207
26. Horsch K, Schaller MD, Hynes NE: The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells. Mol Endocrinol 2001, 15:2182-2196
27. Tonko-Geymayer S, Goupille O, Tonko M, Soratroi C, Yoshimura A, Streuli C, Ziemiecki A, Kofler R, Doppler W: Regulation and function of the cytokine-inducible SH-2 domain proteins, CIS and SOCS3, in mammary epithelial cells. Mol Endocrinol 2002, 16:1680-1695
28. Yamauchi T, Yamauchi N, Ueki K, Sugiyama T, Waki H, Miki H, Tobe K, Matsuda S, Tsushima T, Yamamoto T, Fujita T, Taketani Y, Fukayama M, Kimura S, Yazaki Y, Nagai R, Kadowaki T: Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer. J Biol Chem 2000, 275:33937-33944
29. Imagawa W, Tomooka Y, Hamamoto S, Nandi S: Stimulation of mammary epithelial cell growth in vitro: interaction of epidermal growth factor and mammogenic hormones. Endocrinology 1985, 116:1514-1524
30. Schroeder MD, Symowicz J, Schuler LA: Prolactin modulates cell cycle regulators in mammary tumor epithelial cells. Mol Endocrinol 2002, 16:45-57
31. Rose-Hellekant TA, Gilchrist K, Sandgren EP: Strain background alters mammary gland lesion phenotype in transforming growth factor-alpha transgenic mice. Am J Pathol 2002, 161:1439-1447
32. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE: The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000, 19:968-988
33. Frasor J, Gibori G: Prolactin regulation of estrogen receptor expression. Trends Endocrinol Metab 2003, 14:118-123
34. Gutzman JH, Miller KK, Schuler LA: Endogenous hPRL and not exogenous hPRL induces ERα and PRLR expression and increases estrogen responsiveness in breast cancer cells. J Steroid Biochem Mol Biol 2004, 88:69-77
35. Hennighausen L, Robinson GW: Think globally, act locally: the making of a mouse mammary gland. Genes Dev 1998, 12:449-455
36. Hovey RC, Trott JF, Vonderhaar BK: Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 2002, 7:17-38
37. Clarkson RW, Watson CJ: NF-kappaB and apoptosis in mammary epithelial cells. J Mammary Gland Biol Neoplasia 1999, 4:165-175
38. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K, Vonderhaar BK: Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn 2001, 222:192-205
39. Camarillo IG, Thordarson G, Moffat JG, Van Horn KM, Binart N, Kelly PA, Talamantes F: Prolactin receptor expression in the epithelia and stroma of the rat mammary gland. J Endocrinol 2001, 171:85-95
40. Roovers K, Assoian RK: Integrating the MAP kinase signal into the G1 phase cell cycle machinery. BioEssays 2000, 22:818-826
41. Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL: Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Proc Natl Acad Sci USA 2000, 97:9609-9614
42. Gutzman JH, Nikolai SE, Rugowski DE, Watters JJ, Schuler LA: Prolactin and estrogen enhance the activity of Activating Protein-1 in breast cancer cells: role of ERK1/2-mediated signals to c-fos. Mol Endocrinol 2005, 19:1765-1778
43. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J: Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 2002, 4:556-564
44. Stull MA, Rowzee AM, Loladze AV, Wood TL: Growth factor regulation of cell cycle progression in mammary epithelial cells. J Mammary Gland Biol Neoplasia 2004, 9:15-26
45. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998, 19:225-268
46. Olayioye MA, Neve RM, Lane HA, Hynes NE: The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000, 19:3159-3167
47. Ormandy CJ, Naylor M, Harris J, Robertson F, Horseman ND, Lindeman GJ, Visvader J, Kelly PA: Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res 2003, 58:297-323
48. Buckley AR: Prolactin regulation of cell proliferation and apoptosis. Prolactin. Edited by ND Horseman. Boston, Kluwer Academic Publishers, 2001, pp 247-264
49. Parmar H, Cunha GR: Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr Relat Cancer 2004, 11:437-458
50. Snedeker SM, Brown CF, DiAugustine RP: Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA 1991, 88:276-280
51. Kenney NJ, Smith GH, Rosenberg K, Cutler ML, Dickson RB: Induction of ductal morphogenesis and tabular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ 1996, 7:1769-1781
52. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Reidel RF, Chang A, Lee DC: Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 1999, 126:2739-2750
53. Shoyab M, Plowman GD, Mcdonald VL, Bradley JG, Todaro GJ: Structure and function of human amphiregulin-a member of the epidermal growth factor family. Science 1989, 243:1074-1076
54. Clarke R, Brunner N, Katz D, Glanz P, Dickson RB, Lippman ME, Kern FG: The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human-breast cancer cells in vitro and in vivo. Mol Endocrinol 1989, 3:372-380
55. Ahmed SR, Badger B, Wright C, Manni A: Role of transforming growth factor-α (TGF-α) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGFα and EGF receptor antibodies. J Steroid Biochem Mol Biol 1991, 38:687-693
56. Reddy KB, Yee D, Hilsenbeck SG, Coffey RJ, Osborne CK: Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression. Cell Growth Differ 1994, 5:1275-1282
57. Kenney NJ, Bowman A, Korach KS, Barrett JC, Salomon DS: Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse. Breast Cancer Res Treat 2003, 79:161-173
58. Yarden RI, Wilson MA, Chrysogelos SA: Estrogen suppression of EGFR expression in breast cancer cells: a possible mechanism to modulate growth. J Cell Biochem 2001, 232-246
59. Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE: Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptor alpha expression during tumor progression. Cancer Res 2000, 60:6901-6910
60. Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P: Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis. Cancer Res 2005, 65:3493-3496